Skip to main content

Table 1 Characteristics of participants and examining sites

From: Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study

Participants

 Number of participants

35

 

 Gender (male/female)

10:25

 

 Age (years)

68.7 ± 6.5

 

Examining sites

Healthy

Diseased

 Number of PICF samples

34

40

 PD (mm)

2.32 ± 0.58

4.70 ± 1.36†

 Gingival index

0.0 ± 0.0

1.5 ± 0.5†

 BOP-positive rate (%)

0.0 ± 0.0

40.0 ± 15.2*

 Bone loss rate (%)

19.7 ± 9.8

42.7 ± 18.0†

  1. *P < 0.01 and †P < 0.001 vs healthy group